Iridex Expects 1Q Revenue to Be Flat to Slightly Higher

Dow Jones
04/15

By Katherine Hamilton

Iridex said it expects its first quarter revenue to be flat or slightly higher than the same period last year.

The maker of medical devices for eye diseases said Monday it anticipates revenue to be $11.8 million to $12 million for the quarter ended March 29, compared with $11.8 million in 2024.

Iridex said it was sharing preliminary results to highlight the stabilization of its business and improved financial condition.

Chief Executive Patrick Mercer said Iridex is exposed to external factors including tariff policies, but is still capable of achieving breakeven or better performance.

Preliminary results are based on initial analysis of operations.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

April 14, 2025 16:29 ET (20:29 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10